P207-9129 Screening compound: 3-({(3S,4S)-3-[(tert-butoxycarbonyl)amino]-1-[(9H-fluoren-9-ylmethoxy)carbonyl]piperidin-4-yl}methoxy)benzoic acid

P207-9129 Screening compound: 3-({(3S,4S)-3-[(tert-butoxycarbonyl)amino]-1-[(9H-fluoren-9-ylmethoxy)carbonyl]piperidin-4-yl}methoxy)benzoic acid
P207-9129 Screening compound: 3-({(3S,4S)-3-[(tert-butoxycarbonyl)amino]-1-[(9H-fluoren-9-ylmethoxy)carbonyl]piperidin-4-yl}methoxy)benzoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound P207-9129
3-({(3S,4S)-3-[(tert-butoxycarbonyl)amino]-1-[(9H-fluoren-9-ylmethoxy)carbonyl]piperidin-4-yl}methoxy)benzoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P207-9129

Molecular Formula

C33H36N2O7 (C33 H36 N2 O7)

Compound Name

3-({(3S,4S)-3-[(tert-butoxycarbonyl)amino]-1-[(9H-fluoren-9-ylmethoxy)carbonyl]piperidin-4-yl}methoxy)benzoic acid

IUPAC name

3-{[(3S4S)-3-{[(tert-butoxy)carbonyl]amino}-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl]methoxy}benzoic acid

SMILES

CC(C)(C)OC(N[C@@H](C1)[C@H](COc2cc(C(O)=O)ccc2)CCN1C(OCC1c(cccc2)c2-c2c1cccc2)=O)=O

InChI

InChI=1S/C33H36N2O7/c1-33(2,3)42-31(38)34-29-18-35(16-15-22(29)19-40-23-10-8-9-21(17-23)30(36)37)32(39)41-20-28-26-13-6-4-11-24(26)25-12-5-7-14-27(25)28/h4-14,17,22,28-29H,15-16,18-20H2,1-3H3,(H,34,38)(H,36,37)/t22-,29+/m1/s1

InChI Key

WOQNFPHHDAKBBA-MNNSJKJDSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

572.66

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

7.178

Distribution Coefficient, logD

4.259

Water Solubility, LogSw

-5.59

Polar Surface Area

90.698

Acid Dissociation Constant (pKa)

4.48

Base Dissociation Constant (pKb)

2.72

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

36.36

P207-9129 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with P207-9129 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P207-9129?
Check Price and Availability of P207-9129, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P207-9129 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P207-9129
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P207-9129
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P207-9129 available by request